Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells

被引:91
作者
Sheng, HM
Shao, JY
DuBois, RN
机构
[1] Vanderbilt Univ, Med Ctr, Dept Vet Affairs Med Ctr, Vanderbilt Ingram Canc Ctr,Dept Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Vet Affairs Med Ctr, Vanderbilt Ingram Canc Ctr,Dept Cell Biol, Nashville, TN 37232 USA
关键词
D O I
10.1074/jbc.M010093200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PhosphatidyIinositol 3-kinase (PI3K)/protein kinase B (PKB/Akt) is thought to serve as an oncogenic signaling pathway which can be activated by Ras, The role of PI3K/Akt in Pas-mediated transformation of intestinal epithelial cells is currently not clear. Here we demonstrate that inducible expression of oncogenic Ha-Ras results in activation of PKB/Akt in rat intestinal epithelial cells (RIE-iHa-Ras), which was blocked by treatment with inhibitors of PI3K activity. The PI3K inhibitor, LY-294002, partially reversed the morphological transformation induced by Ha-Pas and resulted in a modest stimulation of apoptosis. The most pronounced phenotypic alteration following inhibition of PI3K was induction of G(1) phase cell cycle arrest. LY-294002 blocked the Ha-Pas-induced expression of cyclin D1, cyclin-dependent kinase (CDK) 2, and increased the levels of p27(kip2). Both LY-294002 and wortmannin significantly reduced anchorage-independent growth of RIE-iHa-Ras cells. Forced expression of both the constitutively active forms of Raf (Delta Raf-22W or Raf BXB) and Akt (Akt-myr) resulted in transformation of RIE cells that was not achieved by transfection with either the Raf mutant construct or Akt-myr alone. These findings delineate an important role for PI3K/Akt in Pas-mediated transformation of intestinal epithelial cells.
引用
收藏
页码:14498 / 14504
页数:7
相关论文
共 57 条
[1]   Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily [J].
Anderson, MJ ;
Viars, CS ;
Czekay, S ;
Cavenee, WK ;
Arden, KC .
GENOMICS, 1998, 47 (02) :187-199
[2]   The Akt kinase:: Molecular determinants of oncogenicity [J].
Aoki, M ;
Batista, O ;
Bellacosa, A ;
Tsichlis, P ;
Vogt, PK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14950-14955
[3]   Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23) [J].
Borkhardt, A ;
Repp, R ;
Haas, OA ;
Leis, T ;
Harbott, J ;
Kreuder, J ;
Hammermann, J ;
Henn, T ;
Lampert, F .
ONCOGENE, 1997, 14 (02) :195-202
[4]  
BOS JL, 1989, CANCER RES, V49, P4682
[5]   Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F [J].
Brennan, P ;
Babbage, JW ;
Burgering, BMT ;
Groner, B ;
Reif, K ;
Cantrell, DA .
IMMUNITY, 1997, 7 (05) :679-689
[6]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[7]   Mutation analysis of the PTEN/MMAC1 gene in cancers of the digestive tract [J].
Chang, JG ;
Chen, YJ ;
Perng, LI ;
Wang, NM ;
Kao, MC ;
Yang, TY ;
Chang, CP ;
Tsai, CH .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (04) :647-651
[8]   Transforming activity and mitosis-related expression of the AKT2 oncogene: Evidence suggesting a link between cell cycle regulation and oncogenesis [J].
Cheng, JQ ;
Altomare, DA ;
Klein, MA ;
Lee, WC ;
Kruh, GD ;
Lissy, NA ;
Testa, JR .
ONCOGENE, 1997, 14 (23) :2793-2801
[9]   ACTIVATION OF MAP KINASE KINASE IS NECESSARY AND SUFFICIENT FOR PC12 DIFFERENTIATION AND FOR TRANSFORMATION OF NIH 3T3 CELLS [J].
COWLEY, S ;
PATERSON, H ;
KEMP, P ;
MARSHALL, CJ .
CELL, 1994, 77 (06) :841-852
[10]   Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241